Nivolumab versus ipilimumab in the treatment of advanced melanoma: a critical appraisal: ORIGINAL ARTICLE: Wolchok JD, Chiarion-Sileni V, Gonzalez R et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 2017; 377:1345-56.

Wan, M T

Nivolumab versus ipilimumab in the treatment of advanced melanoma: a critical appraisal: ORIGINAL ARTICLE: Wolchok JD, Chiarion-Sileni V, Gonzalez R et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 2017; 377:1345-56. [electronic resource] - The British journal of dermatology 08 2018 - 296-300 p. digital

Publication Type: Journal Article; Comment

1365-2133

10.1111/bjd.16785 doi


Adult
Antibodies, Monoclonal
Antineoplastic Combined Chemotherapy Protocols
Humans
Ipilimumab
Melanoma
Nivolumab